Greenwich LifeSciences
GLSI
22 hedge funds and large institutions have $10.2M invested in Greenwich LifeSciences in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
41% more capital invested
Capital invested by funds: $7.21M → $10.2M (+$2.99M)
5% more funds holding
Funds holding: 21 → 22 (+1)
0.96% less ownership
Funds ownership: 6.18% → 5.22% (-0.96%)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$146K |
| 2 |
6CM
683 Capital Management
New York
|
+$134K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$45.2K |
| 4 |
BlackRock
New York
|
+$1.27K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$394K |
| 2 |
Morgan Stanley
New York
|
-$304K |
| 3 |
Millennium Management
New York
|
-$276K |
| 4 |
Renaissance Technologies
New York
|
-$268K |
| 5 |
PVI
Pura Vida Investments
New York
|
-$179K |
GLSI Hedge Fund Activity: Q4 2022 in Review
22 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q4 2022, worth a combined $10.2M — up 41% from $7.21M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GLSI positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 8 trimmed.
The largest buyer was GSA Capital Partners, opening a new position worth an estimated $146K. The largest seller was Marshall Wace, cutting an estimated $394K.
- 22 institutional investors held Greenwich LifeSciences (GLSI) as of Q4 2022, up from 21 in Q3 2022.
- Funds reported $10.2M of Greenwich LifeSciences stock for Q4 2022, up 41% quarter-over-quarter.
- 3 funds opened new Greenwich LifeSciences positions in Q4 2022 and 2 closed out, a net change of +1 holder.
- The largest Greenwich LifeSciences buyer in Q4 2022 was GSA Capital Partners, an estimated $146K added.
- The largest Greenwich LifeSciences seller in Q4 2022 was Marshall Wace, an estimated $394K sold.
Based on aggregated 13F filings for Q4 2022.